MediaPost - Total revenue for Abilify, an anti-psychotic agent for the treatment of schizophrenia, acute bipolar mania and bipolar disorder, increased 34%, to $420 million. U.S. sales increased 27%, to $329 million, primarily due to higher demand and higher ...
